JOURNAL OF CARDIOVASCULAR MEDICINE, vol.16, no.9, pp.603-609, 2015 (SCI-Expanded)
Article / Article
JOURNAL OF CARDIOVASCULAR MEDICINE
Science Citation Index Expanded (SCI-EXPANDED), Scopus
acute heart failure, dobutamine, ivabradine, CORONARY-ARTERY-DISEASE, RATE REDUCTION, CONTROLLED-TRIAL, BETA-BLOCKERS, FUNNY CURRENT, RISK-FACTOR, OUTCOMES, MORTALITY, DEATH
Eskisehir Osmangazi University Affiliated:
Background Ivabradine is a heart rate (HR)-lowering agent acting by inhibiting the I-f-channel. Dobutamine does increase the HR and has some deleterious effects on myocardium. So, we aimed to evaluate whether ivabradine treatment blunts a dobutamine-induced increase in HR.